IFNA2 and hepatocellular carcinoma: After the disappointing results with cytokines (interferon alpha-2b, interleukin-12) [12,13], a better understanding of HCC tumorigenesis and encouraging results were seen with nivolumab opened doors for immunotherapy in HCC [14].